GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » Gross-Profit-to-Asset %

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. The IBN SINA Pharmaceutical Industry's annualized Gross Profit for the quarter that ended in . 20 was BDT Mil. The IBN SINA Pharmaceutical Industry's average Total Assets over the quarter that ended in . 20 was BDT 0 Mil. Therefore, The IBN SINA Pharmaceutical Industry's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.


The IBN SINA Pharmaceutical Industry Gross-Profit-to-Asset % Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry Gross-Profit-to-Asset % Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Gross-Profit-to-Asset %

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset % falls into.



The IBN SINA Pharmaceutical Industry Gross-Profit-to-Asset % Calculation

The IBN SINA Pharmaceutical Industry's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

The IBN SINA Pharmaceutical Industry's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


The IBN SINA Pharmaceutical Industry Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description

Traded in Other Exchanges
N/A
Address
Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Headlines

No Headlines